- Age-dependent transition from islet insulin hypersecretion to hyposecretion in mice with the long QT-syndrome loss-of-function mutation Kcnq1-A340V
- Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
- Long QT syndrome - Bench to bedside
- Diagnostic accuracy of the response to the brief tachycardia provoked by standing in children suspected for long QT syndrome
- Surgical Cardiac Sympathetic Denervation for Ventricular Arrhythmias: A Systematic Review
- Loperamide Toxicity Revealing Apical Hypertrophic Cardiomyopathy
- Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes
- Analysis of the shape of the T-wave in congenital long-QT syndrome type 3 by geometric morphometrics
- Single-centre retrospective analysis of the best timing for the QTc interval length assessment in neonates
- Successful Postnatal Cardiopulmonary Resuscitation Due to Defibrillation
- Genetic Variants Associated With Unexplained Sudden Cardiac Death in Adult White and African American Individuals
- Human iPSC-derived Cardiomyocytes and Pyridyl-Phenyl Mexiletine Analogs
- Use of ECG monitoring for adult patients taking high-risk QT interval-prolonging drugs in clinical practice: a systematic review protocol
- Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome
- Risk factors and predictors of QTc prolongation in critically ill Chinese patients
- Measuring the QT interval on the go
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Diagnosis, management and therapeutic strategies for congenital long QT syndrome
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5
- Measurement of the QT interval using the Apple Watch
- Clinical utility gene card for: Long-QT syndrome
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes
- Elementary mechanisms of calmodulin regulation of NaV1.5 producing divergent arrhythmogenic phenotypes